Literature DB >> 2503225

Depression of maximum rate of depolarization of guinea-pig ventricular action potentials by metabolites of encainide.

P D Hemsworth1, T J Campbell.   

Abstract

1. Standard microelectrode methods have been used to record action potentials from guinea-pig ventricular myocardium and dog Purkinje fibres, and to study the effects of the two major metabolites of encainide, O-desmethyl encainide (ODE) and 3-methoxy-O-desmethyl encainide (MODE). 2. In concentrations similar to those found in patients during chronic encainide therapy, neither ODE nor MODE produced significant depression of maximum rate of depolarization (Vmax) of action potentials in unstimulated tissue. Repetitive stimulation, however, was associated with depression of Vmax which increased with increasing driving rates (rate-dependent block, RDB). At the fastest rate studied (interstimulus interval = 300 ms) ODE 1 microM depressed Vmax by 47.5 +/- 5.7% and MODE 1 microM, reduced Vmax by 52.2 +/- 12%. 3. The onset and offset kinetics of this rate-dependent block were very slow. Full development of RDB during a train required over 100 action potentials and the time constants of recovery of Vmax from RDB were 86.4 +/- 37 s for ODE and 100.4 +/- 18 s for MODE. The amount of RDB and its rate of onset increased with drug concentration. The recovery time constants were independent of inter-stimulus interval or drug concentration. Both metabolites also produced rate-dependent depression of conduction velocity in canine Purkinje fibres, but no evidence of selective depression of conduction of interpolated premature potentials was seen. 4. Early afterdepolarizations occurred spontaneously in three preparations in the presence of MODE, 1 microM and one preparation in ODE, 1 microM. 5. It is concluded that these metabolites of encainide may play a role in producing both its antiarrhythmic and its proarrhythmic effects.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2503225      PMCID: PMC1854529          DOI: 10.1111/j.1476-5381.1989.tb11994.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  28 in total

1.  Selective depression of conduction of premature action potentials in canine Purkinje fibres by class Ib antiarrhythmic drugs: comparison with Ia and Ic drugs.

Authors:  R T Pallandi; T J Campbell
Journal:  Cardiovasc Res       Date:  1988-03       Impact factor: 10.787

2.  Time-independent effects on cardiac action potential upstroke velocity (resting block) and lipid solubility of beta adrenergic blockers.

Authors:  H Sada; T Ban
Journal:  Experientia       Date:  1981-02-15

3.  Effects of encainide and metabolites (MJ14030 and MJ9444) on canine cardiac Purkinje and ventricular fibers.

Authors:  V Elharrar; D P Zipes
Journal:  J Pharmacol Exp Ther       Date:  1982-02       Impact factor: 4.030

4.  Antiarrhythmic properties of MJ 9067 in acute animal models.

Authors:  J E Byrne; A W Gomoll; G R McKinney
Journal:  J Pharmacol Exp Ther       Date:  1977-01       Impact factor: 4.030

5.  Fast frequency-dependent block of action potential upstroke in rabbit atrium by small local anesthetics.

Authors:  K R Courtney
Journal:  Life Sci       Date:  1979-04-23       Impact factor: 5.037

6.  A specific effect of lidocaine and tocainide on ventricular conduction of mid-range extrasystoles.

Authors:  R Y Man; P E Dresel
Journal:  J Cardiovasc Pharmacol       Date:  1979 May-Jun       Impact factor: 3.105

7.  Malignant ventricular tachyarrhythmias associated with the use of encainide.

Authors:  R A Winkle; J W Mason; J C Griffin; D Ross
Journal:  Am Heart J       Date:  1981-11       Impact factor: 4.749

8.  Total suppression of ventricular arrhythmias by encainide. Pharmacokinetic and electrocardiographic characteristics.

Authors:  D M Roden; S B Reele; S B Higgins; R F Mayol; R E Gammans; J A Oates; R L Woosley
Journal:  N Engl J Med       Date:  1980-04-17       Impact factor: 91.245

9.  The relation of Vmax to INa, GNa, and h infinity in a model of the cardiac Purkinje fiber.

Authors:  M Walton; H A Fozzard
Journal:  Biophys J       Date:  1979-03       Impact factor: 4.033

10.  Encainide: a new and potent antiarrhythmic agent.

Authors:  D C Harrison; R Winkle; M Sami; J Mason
Journal:  Am Heart J       Date:  1980-12       Impact factor: 4.749

View more
  1 in total

Review 1.  Subclassification of class I antiarrhythmic drugs: enhanced relevance after CAST.

Authors:  T J Campbell
Journal:  Cardiovasc Drugs Ther       Date:  1992-10       Impact factor: 3.727

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.